Fetal Thalidomide Syndrome Latest Advances

Risk of Falls and Fractures in People with Thalidomide Embryopathy.

Journal: Zeitschrift fur Orthopadie und Unfallchirurgie

Published: September 22, 2025

Cardiovascular manifestations of thalidomide embryopathy.

Journal: VASA. Zeitschrift fur Gefasskrankheiten

Published: July 02, 2025

Secondary musculoskeletal disability and rehabilitation aspects in adults with thalidomide embryopathy: A narrative review.

Journal: Intractable & rare diseases research

Published: May 30, 2025

Ultrasound-Guided Nerve Block With Intravenous Moderate Sedation for Dental Surgery in Thalidomide Embryopathy With Facial Hyperalgesia.

Journal: Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry

Published: April 17, 2025

Thalidomide confers therapeutic benefit in beta thalassemia patients by enhancing hemoglobin and hematopoietic gene expression: A non-randomized clinical trial.

Journal: Blood cells, molecules & diseases

Published: April 13, 2025

Single-Cell Sequencing Reveals Thalidomide-Induced Teratogenicity in Zebrafish via Endoplasmic Reticulum Stress and Dysregulated Angiogenic Signaling.

Journal: The Journal of craniofacial surgery

Published: April 08, 2025

Unexpected absence of fetal hemoglobin induction by lenalidomide in a patient with sickle cell anemia with concurrent multiple myeloma.

Journal: Orphanet journal of rare diseases

Published: January 31, 2025

Thalidomide-induced limb malformations: an update and reevaluation.

Journal: Archives of toxicology

Published: November 18, 2024

Skeletal computed tomography findings of upper extremities in middle-aged persons with thalidomide embryopathy.

Journal: Intractable & rare diseases research

Published: July 18, 2024

Pharmacogenomics of Drugs Used in β-Thalassemia and Sickle-Cell Disease: From Basic Research to Clinical Applications.

Journal: International journal of molecular sciences

Published: March 04, 2024

The impact of ageing on the health and wellbeing of people with thalidomide embryopathy: a comparison of the health impact with the general population.

Journal: Disability and rehabilitation

Published: February 06, 2024

AGA Clinical Practice Update on Pregnancy-Related Gastrointestinal and Liver Disease: Expert Review.

Journal: Gastroenterology

Published: December 13, 2023

Fetal Thalidomide Syndrome Latest Advances

Find the Latest Research About Fetal Thalidomide Syndrome

Risk of Falls and Fractures in People with Thalidomide Embryopathy.

Risk of Falls and Fractures in People with Thalidomide Embryopathy.

Cardiovascular manifestations of thalidomide embryopathy.

Cardiovascular manifestations of thalidomide embryopathy.

Secondary musculoskeletal disability and rehabilitation aspects in adults with thalidomide embryopathy: A narrative review.

Secondary musculoskeletal disability and rehabilitation aspects in adults with thalidomide embryopathy: A narrative review.

Ultrasound-Guided Nerve Block With Intravenous Moderate Sedation for Dental Surgery in Thalidomide Embryopathy With Facial Hyperalgesia.

Ultrasound-Guided Nerve Block With Intravenous Moderate Sedation for Dental Surgery in Thalidomide Embryopathy With Facial Hyperalgesia.

Thalidomide confers therapeutic benefit in beta thalassemia patients by enhancing hemoglobin and hematopoietic gene expression: A non-randomized clinical trial.

Thalidomide confers therapeutic benefit in beta thalassemia patients by enhancing hemoglobin and hematopoietic gene expression: A non-randomized clinical trial.

Single-Cell Sequencing Reveals Thalidomide-Induced Teratogenicity in Zebrafish via Endoplasmic Reticulum Stress and Dysregulated Angiogenic Signaling.

Single-Cell Sequencing Reveals Thalidomide-Induced Teratogenicity in Zebrafish via Endoplasmic Reticulum Stress and Dysregulated Angiogenic Signaling.

Unexpected absence of fetal hemoglobin induction by lenalidomide in a patient with sickle cell anemia with concurrent multiple myeloma.

Unexpected absence of fetal hemoglobin induction by lenalidomide in a patient with sickle cell anemia with concurrent multiple myeloma.

Thalidomide-induced limb malformations: an update and reevaluation.

Thalidomide-induced limb malformations: an update and reevaluation.

Skeletal computed tomography findings of upper extremities in middle-aged persons with thalidomide embryopathy.

Skeletal computed tomography findings of upper extremities in middle-aged persons with thalidomide embryopathy.

Pharmacogenomics of Drugs Used in β-Thalassemia and Sickle-Cell Disease: From Basic Research to Clinical Applications.

Pharmacogenomics of Drugs Used in β-Thalassemia and Sickle-Cell Disease: From Basic Research to Clinical Applications.

The impact of ageing on the health and wellbeing of people with thalidomide embryopathy: a comparison of the health impact with the general population.

The impact of ageing on the health and wellbeing of people with thalidomide embryopathy: a comparison of the health impact with the general population.

AGA Clinical Practice Update on Pregnancy-Related Gastrointestinal and Liver Disease: Expert Review.

AGA Clinical Practice Update on Pregnancy-Related Gastrointestinal and Liver Disease: Expert Review.